Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Parkinson's Disease

  Free Subscription

Articles published in J Clin Pharmacol

Retrieve available abstracts of 6 articles:
HTML format

Single Articles

    March 2021
  1. GRIEB P, Swiatkiewicz M, Prus K, Rejdak K, et al
    Amantadine for COVID-19.
    J Clin Pharmacol. 2021;61:412-413.

    February 2020
  2. YOU X, Wu W, Xu J, Jiao Z, et al
    Development of a Physiologically Based Pharmacokinetic Model for Prediction of Pramipexole Pharmacokinetics in Parkinson's Disease Patients With Renal Impairment.
    J Clin Pharmacol. 2020 Feb 24. doi: 10.1002/jcph.1593.
    PubMed     Abstract available

  3. SATHE AG, Tuite P, Chen C, Ma Y, et al
    Pharmacokinetics, Safety, and Tolerability of Orally Administered Ursodeoxycholic Acid in Patients With Parkinson's Disease-A Pilot Study.
    J Clin Pharmacol. 2020 Feb 12. doi: 10.1002/jcph.1575.
    PubMed     Abstract available

    February 2019
  4. DAMASCENO DOS SANTOS EU, Duarte EBC, Miranda LMR, Asano AGC, et al
    Pharmacogenetic Profile and the Occurrence of Visual Hallucinations in Patients With Sporadic Parkinson's Disease.
    J Clin Pharmacol. 2019 Feb 22. doi: 10.1002/jcph.1394.
    PubMed     Abstract available

    March 2018
  5. SAMPAIO TF, Dos Santos EUD, de Lima GDC, Dos Anjos RSG, et al
    MAO-B and COMT Genetic Variations Associated With Levodopa Treatment Response in Patients With Parkinson's Disease.
    J Clin Pharmacol. 2018 Mar 26. doi: 10.1002/jcph.1096.
    PubMed     Abstract available

    September 2017
  6. COLES LD, Tuite PJ, Oz G, Mishra UR, et al
    Repeated-Dose Oral N-Acetylcysteine in Parkinson's Disease: Pharmacokinetics and Effect on Brain Glutathione and Oxidative Stress.
    J Clin Pharmacol. 2017 Sep 22. doi: 10.1002/jcph.1008.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.